Addentax Group Corp. — Form 10-Q Summary
Reporting period: Three months ended June 30, 2020, compared with the three months ended June 30, 2019. The filing is dated August 14, 2020. Amounts are U.S. dollars unless noted.
Business context
Addentax operates garment manufacturing, logistics services, and epidemic-prevention supplies businesses, primarily in China. The epidemic-prevention supplies business began contributing revenue in the current quarter. Common stock traded on OTC Markets under ATXG.
Financial performance and liquidity
| Metric | Three months ended June 30, 2020 | Prior-year period / comparison |
|---|---|---|
| Revenue | $5.918 million | $2.209 million; up 167.9% |
| Gross profit / margin | $797,639 / 13.5% | $357,932 / 16.2% |
| Operating income (loss) | $188,432 | $(353,741) |
| Net income (loss) | $203,900; $0.01 per share | $(367,348); reported EPS $(0.00) |
| Operating cash flow | $798,391 | $(328,769) |
| Cash at quarter end | $1,549,409 | $531,681 at March 31, 2020 |
Revenue by segment was $3.110 million from epidemic-prevention supplies (52.6% of total), $1.533 million from logistics (25.9%), and $1.275 million from garments (21.5%). Segment gross margins were 14.7%, 16.1%, and 7.2%, respectively.
At June 30, current assets were $4.528 million and current liabilities were $8.516 million, resulting in net current liabilities of $3.988 million. Total liabilities were $9.801 million; total equity was a deficit of $2.867 million. The company had $353,854 of short-term bank loans and $5.796 million due to related parties. Related-party balances were unsecured, non-interest-bearing, and payable on demand. Lease liabilities totaled $1.713 million, including $428,198 current.
Operating cash flow included a $2.823 million cash inflow from the reduction in accounts receivable, partly offset by a $2.088 million reduction in accounts payable. Investing cash outflow was $143,148, principally for equipment; financing cash inflow was $360,386 net, after related-party borrowings and repayments.
Material changes and management commentary
- Revenue growth was driven by the new epidemic-prevention supplies business and higher garment revenue, partly offset by lower logistics revenue. Management attributed logistics weakness to COVID-19-related disruption.
- Epidemic-prevention supplies generated $3.110 million in revenue, including $3.042 million from merchandise trading. Its reported gross profit was $458,553.
- Garment revenue rose, but gross margin declined to 7.2% from 18.4%; management cited higher raw-material prices and labor costs.
- Total gross margin declined to 13.5% from 16.2%, as cost of revenue increased faster than revenue. General and administrative expense declined 35.3%, while selling expense rose substantially, primarily with the new supplies business.
- Cash increased from March 31, while accounts receivable fell from $4.500 million to $1.677 million. Five customers represented 68.5% of receivables at June 30; no doubtful-account allowance was recorded.
Outlook, risks and unusual items
- Going concern: Management disclosed substantial doubt about the company’s ability to continue as a going concern, citing net current liabilities, an accumulated equity deficit, and reliance on future profits and financing. The company expects to rely on operating cash flows and CEO support; the CEO indicated intent and ability to provide additional equity, but there is no assurance of funding.
- Liquidity and debt: Management stated that additional capital is needed and that current resources are inadequate for short- and long-term objectives. The $141,543 Agricultural Bank of China loan was due in July 2020 and the $212,334 Dongguan Agricultural Commercial Bank loan was due in September 2020. The filing does not clarify whether these obligations were subsequently repaid or refinanced.
- Business risks: Management cited economic uncertainty, pricing pressure, customer and supplier credit risks, competition, and RMB/U.S. dollar exchange-rate exposure. It also noted supplier concentration: the five largest suppliers accounted for approximately 98% of inventory purchases in the quarter.
- Controls: Management concluded that disclosure controls and internal control over financial reporting were ineffective due to a material weakness: insufficient personnel with appropriate accounting knowledge, experience, and training.
- Other: The company reported no material legal proceedings, no off-balance-sheet arrangements, and no subsequent events requiring disclosure. No quantified earnings or revenue guidance was provided. The quarter included a $475,003 goodwill impairment recorded as of March 31, 2020; goodwill was nil at both March 31 and June 30.
Key facts investors should verify
- Whether the company secured adequate financing and met the July and September 2020 bank-loan maturities, and the status of substantial related-party payables due on demand.
- Whether the new epidemic-prevention supplies revenue and margins were sustainable, and how exposed results were to trading merchandise and pandemic-related demand.
- Collectability of receivables, customer concentration, and the rationale for recording no allowance despite the disclosed concentration and economic uncertainty.
- Resolution of the filing’s segment-profit inconsistencies: the segment table reports epidemic-prevention operating income of $288,717, while MD&A states $369,578; it also reports consolidated operating income of $188,432.
- Remediation progress for the material weakness and whether financial-reporting controls became effective.